'Virological failure' presentation slideshows

724 views • 59 slides

Describing the risk of an event and identifying risk factors

Describing the risk of an event and identifying risk factors. Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection and Population Health, Division of Population Health, Royal Free and UC Medical School. Studying the risk of an event.

573 views • 46 slides

Martinez E et al . AIDS 2010

Martinez E. 1 , Larrousse M. 1 , Llibre J.M. 2 , Gutierrez F. 3 , Saumoy M. 4 , Antela A. 5 , Knobel H. 6 , Pich J. 1 , Perez I. 1 , J. Murillas 7 , J. Portilla 8 , J. Berenguer 9 , E. Ribera 10 and Gatell J.M. 1 , for the SPIRAL study group.

506 views • 37 slides

BHIVA Clinical Audit

384 views • 37 slides

Virological predictors of clinical outcome

Virological predictors of clinical outcome. Anna Maria Geretti Royal Free Hampstead NHS Trust & UCL Medical School London. Mortality risk with detectable viraemia during HAART. Cumulative mortality stratified by % VL ?400 cps/ml recorded during 18 months after HAART initiation.

415 views • 34 slides

BHIVA Clinical Audit

491 views • 30 slides

BHIVA Clinical Audit

306 views • 30 slides

EARLY SIMPLIFIED TRIAL

291 views • 27 slides

HAART in Patients with Advanced Disease (<200 CD4 + cell/mm 3 )

394 views • 23 slides

4th IAS Conference on HIV Pathogenesis, Treatment and Prevention

4th IAS Conference on HIV Pathogenesis, Treatment and Prevention Sydney, Australia, July 22-26, 2007 WEPEB117LB.

238 views • 23 slides

Treatment Failure

Treatment Failure. HAIVN Harvard Medical School AIDS Initiative in Vietnam. Learning Objectives. At the end of this presentation, participants should be able to: Recognize the importance of diagnosing treatment failure Know the definitions of treatment failure

416 views • 20 slides

Why we need a better first line, access to viral load and alternative drugs for treatment failure.

280 views • 20 slides

Dr Charlotte CHARPENTIER Laboratoire de Virologie CHU Bichat-Claude Bernard

Poster WEPDB0102. Persistent Low-Level HIV-1 RNA between 20 and 50 copies/mL in Antiretroviral-Treated Patients: Associated Factors and Virological Outcome. Dr Charlotte CHARPENTIER Laboratoire de Virologie CHU Bichat-Claude Bernard

166 views • 4 slides

N: 81 35 14 7 6 2 1

SDC 3: Time until virologic suppression and failure. Duration until subsequent virological failure. Duration until first virological suppression. N: 81 35 14 7 6 2 1

110 views • 1 slides

INTRODUCTION

173 views • 1 slides

Viral load blips in HIV infected children from the CHIPS cohort: what do they mean?

Background. At blip. Difference to. Difference to. Table 2: Summary of CD4 and CD8 before, during and after a blip. previous. post. 3. CD4 (cells/mm. ). 858 (634. -. 1314). -. 20 (. -. 127. -. +140). +17 (. -. 117. -. +130). p=0.85. p=0.44. 3. CD8 (cells/mm. ).

121 views • 1 slides